FIG. 151 Ethmoid bone from behind. FIG. 152 Ethmoid bone from the right side. FIG. 153 Lateral wall of nasal cavity, showing ethmoid bone in position. In front of the lamina papyracea are some broken air cells which are overlapped and completed by the lacrimal bone and the frontal process of the maxilla.IG. 151 Ethmoid bone from behind. FIG. 152 Ethmoid bone from the right side. FIG. 153 Lateral wall of nasal cavity, showing ethmoid bone in position. In front of the lamina papyracea are some broken air cells which are overlapped and completed by the lacrimal bone and the frontal process of the maxilla.
Nusinersen sodium is administered intrathecally.1. 1  Dosing Information1. 2  Available as nusinersen sodium; dosage expressed in terms of nusinersen.1. 3  The recommended dosage is 12 mg (5 mL) per administration. 1.
Lorazepam: reduction of recommended maximum daily dose. Maximum dose of lorazepam for short term, symptomatic treatment is 4 mg per day for severe, disabling anxiety, and 2 mg per day for severe, disabling insomnia. Article date: October 2007. Lorazepam is a benzodiazepine anxiolytic; its indications include short-term use in anxiety or insomnia. Doses of lorazepam above 4 mg per day are not considered appropriate in view of the recommended maximum treatment duration of 4 weeks, which includes a dose-reduction period.